| 1. | 王海燕. 腎臟病學[M]. 北京: 人民衛生出版社, 1997: 708-719. | 
				                                                        
				                                                            
				                                                                | 2. | Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease[J]. Hum Pathol, 1982, 13(4): 314-322. | 
				                                                        
				                                                            
				                                                                | 3. | 肖俊, 朱玲燕, 陳崴, 等. 調節性及輔助性T細胞在人類IgA腎病中的表達及意義[J]. 中華腎臟病雜志, 2008, 24(8): 544-549. | 
				                                                        
				                                                            
				                                                                | 4. | Layward L, Allen AC, Hattersley JM, et al. Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass[J]. Nephrol Dial Transplant, 1993, 8(1): 25-28. | 
				                                                        
				                                                            
				                                                                | 5. | Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity[J]. J Clin Invest, 2009, 119(6): 1668-1677. | 
				                                                        
				                                                            
				                                                                | 6. | Leusehner U. Primary biliary cirrhesis-presentation and diagnosis[J]. Clin Liver Dis, 2003, 7(4): 741-758. | 
				                                                        
				                                                            
				                                                                | 7. | Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1[J]. J Clin Invest, 2008, 118(2): 629-639. | 
				                                                        
				                                                            
				                                                                | 8. | Hazzan R, Mukamel M,Yacobovich J, et al. Risk factors for future development ofsystemic lupus erythematosus in children with idiopathic thrombocytopenic purpura[J]. Pediatr Blood Cancer, 2006, 47(5 Suppl): 657-659. | 
				                                                        
				                                                            
				                                                                | 9. | Irie F, Kobayashi M, Hirayama K, et al. Rheumatoid arthritis associated with membranous nephropathy and lgA nephritis with necrotizing lesions[J]. Nephrol Dial Transplant, 1996, 11(7): 1338-1341. | 
				                                                        
				                                                            
				                                                                | 10. | Yen TH, Lai PC, Chen CC, et al. Renal involvement in patients with polymyositis and dermatomyositis[J]. Int J Clin Pract, 2005, 59(2): 188-193. | 
				                                                        
				                                                            
				                                                                | 11. | Horino T, Takao T, Terada Y. IgA nephmpathy in a patient with systemic lupus erythenlatosus[J]. Lupus, 2010, 19(5): 650-654. | 
				                                                        
				                                                            
				                                                                | 12. | Watanabe M, Fujimoto T, Iwano M, et al. Report of patient of primary, IgA nephropathy and chronic idiopathic thrombocytopenic purpura[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2002, 25(2): 191-198. | 
				                                                        
				                                                            
				                                                                | 13. | Schwab N, Zozulya AL, Kieseier BC, et al. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in muhiple sclerosis[J]. J Immunol, 2010, 184(9): 5368-5374. | 
				                                                        
				                                                            
				                                                                | 14. | Kwan BC, Tam LS, Lai KB, et al. The gene expression of type 17 T helper cell-related cytokines in the urinary sediment of patients with systemic lupus crytheH1atous[J]. Rheumatology (Oxford), 2009, 48(12): 1491-1497. | 
				                                                        
				                                                            
				                                                                | 15. | Yu H, Huang J, Liu Y, et al. IL-17 contributes to autoimmune hepatitis[J]. J Huazhong Univ Sci Technol Med Sci, 20l0, 30(4): 443-446. | 
				                                                        
				                                                            
				                                                                | 16. | Hemdan NY, Birkenmeier G, Wichmann G, et al. Interleukin-17-producing T helper cells in autoimmunity[J]. Autoimmun Rev, 2010, 9(11): 785-792. |